<DOC>
	<DOCNO>NCT01560715</DOCNO>
	<brief_summary>The purpose study evaluate short-term safety efficacy single intravitreal injection autologous bone marrow stem cell patient retinitis pigmentosa .</brief_summary>
	<brief_title>Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa</brief_title>
	<detailed_description>A prospective phase II , nonrandomized open-label study retinitis pigmentosa patient best-corrected ETDRS visual acuity ( BCVA ) bad 20/200 . Standardized ophthalmic evaluation perform baseline week 1 , 4,12 24 ( Â±1 ) follow intravitreal injection 10 x 106 bone marrow stem cells/ 0,1ml . Three measure use evaluate short-term safety intravitreal ABMDSC : 1 ) severe visual loss , define drop 15 letter ETDRS visual acuity scale ; 2 ) decrease ERG response ; 3 ) decrease 5 square degree visual field ; secondary safety outcome : 1 ) increase intra-ocular inflammation define herein anterior chamber cell flare high 3+ 1 month injection accord classification described elsewhere ; 2 ) decrease CMT 50um ; 3 ) genesis abnormal tissue ( teratoma ) tumor ; 4 ) qualitative change retinal choroidal perfusion , like macular nonperfusion . Secondary outcome measure use evaluate short-term efficiency intravitreal ABMDSC : 1 ) improvement ERG response ; 2 ) increase visual field : 3 ) increase CSMT &gt; 50um related macular edema ; 4 ) increase &gt; 5 letter BCVA</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<criteria>diagnosis retinitis pigmentosa logarithm minimum angle resolution ( logMAR ) BCVA 1.0 ( Snellen equivalent , 20/200 ) bad visual Field le 20 degreees previous ocular surgery cataract presence cataract medium opacity would influence ocular fundus documentation adequate ERG visual field evaluation ophthalmic disease like glaucoma uveitis previous history blood disorder like leukemia know allergy fluorescein indocyanine green know coagulation abnormality current use anticoagulative medication aspirin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Retinitis pigmentosa</keyword>
	<keyword>stem cell</keyword>
	<keyword>bone marrow</keyword>
	<keyword>retinal dysprophy</keyword>
</DOC>